Artivion, Inc.
AORT
NYSE·Healthcare·Medical - Devices·Mkt cap $1.2B
$25.57
▼ -0.20%
P/E
-356.62
Mkt Cap
$1.2B
52-Wk Range
$19.16–$48.25
52-Week Range
$19.16 - $48.25
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 41.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- Proprietary tissue preservation technology with established clinical track record
- Diversified product portfolio spanning surgical adhesives, implants, and endovascular devices
- Strong intellectual property portfolio and regulatory approvals across major markets
- Established relationships with cardiac surgeons and interventional specialists globally
- Integrated manufacturing and processing capabilities for complex medical devices
- Proven expertise in biomaterial science and pyrolytic carbon coating services
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Steady revenue growth (14% YoY)
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+25.4% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying AORT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of -$0.28 vs $0.00 consensus (-11300.0% surprise). Revenue of $125.8M vs $120.0M expected (+4.8%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-11300.0%
Revenue trend · last 8Q
—
+4%
+2%
+15%
+18%
+19%
+18%
+11%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$95.8M
$97.3M
$99.0M
$113.0M
$113.4M
$116.0M
$116.3M
$125.8M
Margins · last 8Q
Gross
67.1%
Operating
-8.0%
Profit
-10.7%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Stifel · $45.00 · Jun 1, 2026
vs Industry
How AORT stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related